Cepheid Awarded NIH Research Grant for Rapid Diagnostic Testing of Tuberculosis
SUNNYVALE, Calif. -- Cepheid announces it has been awarded a grant from the National Institutes of Health to develop rapid diagnostic tests for Mycobacteria tuberculosis.
The project, which is a collaborative effort between Cepheid and the University of Medicine and Dentistry of New Jersey (UMDNJ), involves the development of rapid diagnostic test protocols, procedures and reagents using Cepheid's GeneXpert platform. Dr. David Alland, associate professor of medicine at the UMDNJ Center for Emerging and Re-emerging Pathogens and a nationally renowned expert in antibiotic resistance of TB, is directing the UMDNJ effort. The one-year NIH grant to Cepheid will total $376,000.
"The GeneXpert system is ideally suited to this type of test because of its speed, its automated sample processing capability, and its ability to detect multiple DNA sequences in the same reaction. This ability will allow rapid, real-time analysis of antibiotic resistance. Scheduled for market availability in 2003, the GeneXpert is designed to provide a fully automated genetic assessment result, sample in answer out," said Kurt Petersen, Cepheid president and chief operating officer.
Alland said, "Innovative methods for sample processing have lagged behind recent technological advances in DNA amplification and detection. Rapid and efficient sample processing are essential elements of truly user-friendly diagnostic assays. Cepheid's technology is ideally suited to this project. Our goal is to develop a diagnostic system for TB and drug resistant TB that can be used anywhere in the world by individuals with minimal training."
Source: PR Newswire
Newsletter
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.
